Survival time for prostate cancer patients is generally 5 to 10 years, with survival rates of 90% to 95% for early-stage patients, 70% to 80% for locally progressive stages, and only about 30% for late-stage patients.
Usually, prostate cancer grows slowly and is not easy to develop distant metastasis. Patients can mostly survive for 5~10 years after timely standardized treatment and the prognosis is better. In general, patients with early stage limited prostate cancer, the survival rate of 5~10 years reaches more than 90%~95%, while for patients with localized progressive stage, the survival rate of 5~10 years is mostly 70%~80%.
If the patient’s condition is more serious and belongs to advanced metastatic prostate cancer, it is also necessary to combine various modalities of treatment, and most of the patients can survive for about 5 years after standardized treatment, and their survival rate is relatively low, about 30%. Therefore, after the disease is diagnosed, patients need to seek medical treatment in time and follow the doctor’s instructions to carry out reasonable treatment, so as to avoid delaying the condition and affecting the survival time.
It is recommended that prostate cancer patients actively cooperate with doctors for treatment according to their own conditions.